Crispr Therapeutics
Price & Volume
Stats
See moreOpen | $59 |
Previous Close | $61.74 |
Day Range | $58.59-$61.36 |
52W Range | $30.04-$78.48 |
Market Cap | $5.2B |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $3.5M |
Revenue Growth (YoY) | -97.6% |
Gross Profit (12 Mos) | -$494.7M |
Diluted EPS | -$6.47 |
News
See moreYahoo Finance • 7 days ago
Genomics Stocks That Deserve a Place in Your Portfolio in 2026
Yahoo Finance • 7 days ago
The Gene‑Therapy Breakthrough Story You'll Be Mad You Ignored at These Prices
Yahoo Finance • 13 days ago
Crispr Therapeutics price target raised to $74 from $62 at Evercore ISI
About
CEO | Dr. Samarth Kulkarni Ph.D. |
Address | Baarerstrasse 14, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 393 |
